Zimmer Biomet Holdings (ZBH) Capital Expenditures (2009 - 2026)

Zimmer Biomet Holdings has reported Capital Expenditures for 18 years, with the latest figure at $36.3 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 18.61% year-over-year to $36.3 million; the trailing twelve-month figure through Mar 2026 stood at $216.2 million (up 11.85% YoY), and the FY2025 full-year result was $224.5 million, up 10.16% from the prior year.
• Capital Expenditures for Q1 2026 stood at $36.3 million, down from $74.8 million in the prior quarter.
• The five-year high for Capital Expenditures was $97.3 million in Q2 2023, with the low at $36.3 million in Q1 2026.
• Average Capital Expenditures over 5 years is $55.5 million, with a median of $51.5 million recorded in 2024.
• Year-over-year, Capital Expenditures soared 137.9% in 2023 and plunged 47.21% in 2024.
• Tracing ZBH's Capital Expenditures over 5 years: stood at $63.4 million in 2022, then dropped by 0.95% to $62.8 million in 2023, then slipped by 17.99% to $51.5 million in 2024, then jumped by 45.24% to $74.8 million in 2025, then sank by 51.47% to $36.3 million in 2026.
• The last three Capital Expenditures figures came in at $36.3 million (Q1 2026), $74.8 million (Q4 2025), and $55.0 million (Q3 2025), per Business Quant data.

Peer Comparison